according to the modern pathophysiological understanding of type 2 diabetes and the mechanisms of sulfonylurea action , combined insulin-sulfonylurea therapy appears to be an interesting alternative for treating diabetic patients with secondary failure to sulfonylureas .
C0011860
type 2 diabetes
C0021641
insulin